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Background
Atrial natriuretic peptide (ANP) has been used clinically
for the treatment of heart failure patients in Japan, and
also exhibits a variety of physiological effects through
binding guanylyl cyclase-A (GC-A) receptor. We and
other groups has been reported that GC-A is abundantly
expressed in endothelial cells. In the present study, we
explored the therapeutic potential of endothelial ANP/
GC-A system for the treatment of metabolic syndrome.
Methods
We generated endothelial cell-specific GC-A transgenic
mice using Tie2 promoter and enhancer (EC-GC-A-Tg),
inducible endothelial cell-specific GC-A transgenic mice
(Inducible EC-GC-A-Tg), and also endothelial cell-speci-
fic GC-A knockout mice (EC-GC-A-KO). In addition,
we used eNOS transgenic mice (eNOS-Tg). For the eva-
luation of blood pressure, telemetry system and tail-cuff
method were used. Insulin resistance was evaluated by
intra-peritoneal glucose tolerance test (IPGTT) and
intra-peritoneal insulin tolerance test (IPITT).
Results
The phenotypes of EC-GC-A-Tg were very unique.
Systolic blood pressure in EC-GC-A-Tg was significantly
lower compared with wild-type mice (WT). In addition,
heat weight/body weight ratio and arterial elastance were
smaller and lower in EC-GC-A-Tg compared with WT.
Synchrotron radiation angiography showed decrease of
basal vascular tone in EC-GC-A-Tg and increase in EC-
GC-A-KO compared with in each control mice. Basal
body weight of WT and EC-GC-A-Tg, flox mice and EC-
GC-A-KO were comparable. However, after taking
8 weeks of high-fat diet, increase of body weight of EC-
GC-A-Tg was significantly less than WT. On the other
hand, EC-GC-A-KO showed more than increase of body
weight. IPGTT and IPITT showed improvement of insu-
lin tolerance in EC-GC-A-Tg, and worsen in EC-GC-A-
KO compared with in each control mice. Interestingly,
Inducible EC-GC-A-Tg showed less increase of body
weight accompanied by aging. The body weight of
eNOS-Tg was comparable with WT before and after tak-
ing 8 weeks of high-fat diet.
Conclusion
These data suggest that endothelial ANP/GC-A system
can be a therapeutic target for metabolic syndrome.
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